Matches in Wikidata for { <http://www.wikidata.org/entity/Q87829268> ?p ?o ?g. }
- Q87829268 description "2019 թվականին հրատարակված գիտական հոդված" @default.
- Q87829268 description "article scientifique (publié 2019)" @default.
- Q87829268 description "articolo scientifico (pubblicato il 2019)" @default.
- Q87829268 description "artigo científico (publicado na 2019)" @default.
- Q87829268 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q87829268 description "artículo científico publicado en 2019" @default.
- Q87829268 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q87829268 description "im Jahr 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q87829268 description "scientific article published on 01 January 2019" @default.
- Q87829268 description "wetenschappelijk artikel" @default.
- Q87829268 description "наукова стаття, опублікована 1 січня 2019" @default.
- Q87829268 description "научна статия" @default.
- Q87829268 name "Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis" @default.
- Q87829268 name "Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis" @default.
- Q87829268 name "Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis" @default.
- Q87829268 type Item @default.
- Q87829268 label "Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis" @default.
- Q87829268 label "Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis" @default.
- Q87829268 label "Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis" @default.
- Q87829268 prefLabel "Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis" @default.
- Q87829268 prefLabel "Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis" @default.
- Q87829268 prefLabel "Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis" @default.
- Q87829268 P1433 Q87829268-4F8790AA-9341-4D02-AC73-293A8D9A1530 @default.
- Q87829268 P1476 Q87829268-AC48673B-18E0-469E-9EDD-7522FDD0469C @default.
- Q87829268 P2093 Q87829268-0AF79844-999C-4382-8624-06011BDDB08E @default.
- Q87829268 P2093 Q87829268-0BC74B02-68AA-4958-928C-FDDABAE30442 @default.
- Q87829268 P2093 Q87829268-13B84048-E736-4084-B247-9EF9B55BAFC7 @default.
- Q87829268 P2093 Q87829268-41C15ABC-A9B2-418A-A4F3-289A0339419D @default.
- Q87829268 P2093 Q87829268-41CBDE72-0ABB-4A79-A94A-E2ABFEBA6CFD @default.
- Q87829268 P2093 Q87829268-778D9588-503C-4ACB-8F64-0C73E028D7DD @default.
- Q87829268 P2093 Q87829268-87F590F5-CABB-4A78-853E-9E8BBE0535E9 @default.
- Q87829268 P2093 Q87829268-A407EB65-8AC4-482A-A17A-59F34B738AE5 @default.
- Q87829268 P2093 Q87829268-A525D0AF-4A15-4EF8-B0A6-ED4AD651B358 @default.
- Q87829268 P2093 Q87829268-D8A73242-2D83-4B40-AEC9-C5178C6746A5 @default.
- Q87829268 P2093 Q87829268-FDA2822D-D3EE-4AB7-8D34-7AB3B0137F79 @default.
- Q87829268 P275 Q87829268-5e993f26-8412-4e8f-a543-f5363de7bb61 @default.
- Q87829268 P2860 Q87829268-075A75CF-44E6-4D69-8AC2-C967D8AD67BE @default.
- Q87829268 P2860 Q87829268-15B2BB5C-626D-4235-9C36-D1C7C79070B6 @default.
- Q87829268 P2860 Q87829268-1A966D3E-C76F-4A5E-81D3-291477386F37 @default.
- Q87829268 P2860 Q87829268-1F617313-DD7F-4D3E-B631-4A4EF61A2417 @default.
- Q87829268 P2860 Q87829268-203BDCD3-9811-4A36-B87F-5DD82A8E1103 @default.
- Q87829268 P2860 Q87829268-278867C0-B7D6-46B4-B4FF-26CBDA6B8EBD @default.
- Q87829268 P2860 Q87829268-2937824C-97CD-4018-A739-7F66571C6C75 @default.
- Q87829268 P2860 Q87829268-2BB46749-670D-457D-A57C-525A52030B18 @default.
- Q87829268 P2860 Q87829268-2FFF2164-22B3-49FC-BAAD-C8CF7DF271BE @default.
- Q87829268 P2860 Q87829268-320CBFB9-DE99-40A5-BBC5-A385957ECDDA @default.
- Q87829268 P2860 Q87829268-3B1C4C19-0DDD-4600-999D-06C8F851A2F2 @default.
- Q87829268 P2860 Q87829268-3CBB5DC7-7F73-49BE-84BF-B1DD5B7D3AEC @default.
- Q87829268 P2860 Q87829268-45B7184F-FFEB-40DC-BC5B-AB62A273ED19 @default.
- Q87829268 P2860 Q87829268-47FDEC5F-E11D-4564-95FB-88B713956F2F @default.
- Q87829268 P2860 Q87829268-518B0191-7E99-4BCF-A5AA-C876BF4631C9 @default.
- Q87829268 P2860 Q87829268-5985B619-0E7A-4E54-9A80-1776EB18A807 @default.
- Q87829268 P2860 Q87829268-5D674E8E-99AA-4708-A49D-77CDE9C07941 @default.
- Q87829268 P2860 Q87829268-5F1BD965-556B-4249-9AA1-5A761E97D0C0 @default.
- Q87829268 P2860 Q87829268-60244A21-8ADC-4447-8990-EC3F8D6D0BFE @default.
- Q87829268 P2860 Q87829268-60624454-521B-426E-9CDF-C5C08D61E52A @default.
- Q87829268 P2860 Q87829268-62E23D51-23BC-49C9-9F47-AFC4FBCFACE9 @default.
- Q87829268 P2860 Q87829268-63E3EE9B-C7C2-4E88-834B-6900DCE3B9B8 @default.
- Q87829268 P2860 Q87829268-68F17EF6-C012-4444-A916-03440FF314DD @default.
- Q87829268 P2860 Q87829268-6AB59397-EED9-4426-A74D-6330687BFE0B @default.
- Q87829268 P2860 Q87829268-6AC638CD-CF8C-4373-A99A-26221CFD322D @default.
- Q87829268 P2860 Q87829268-770A2BBE-9D53-4A2E-8CDE-C53F0B960D73 @default.
- Q87829268 P2860 Q87829268-7D8D0F21-0DD3-4DE2-BA8B-B40EC2AB6C1D @default.
- Q87829268 P2860 Q87829268-8672DCCD-90C6-4C83-B6C9-9FE71A29AFF9 @default.
- Q87829268 P2860 Q87829268-87253DAE-7698-4D7C-B74D-BDAA04CD98E9 @default.
- Q87829268 P2860 Q87829268-95516F65-8014-4E40-8707-378D919A7147 @default.
- Q87829268 P2860 Q87829268-9B3DCE42-D26B-4A3C-9A2C-6CB729D5383F @default.
- Q87829268 P2860 Q87829268-9F1DD333-D84F-4488-9192-36E210005122 @default.
- Q87829268 P2860 Q87829268-ADF5BD46-B0B0-4B25-856A-15F22C079270 @default.
- Q87829268 P2860 Q87829268-AE71FE36-FBD1-4772-991F-88873D71172F @default.
- Q87829268 P2860 Q87829268-B3DC7F3E-39A0-4276-9BC2-336D683A0C29 @default.
- Q87829268 P2860 Q87829268-BC0E4A8A-89E7-4DF1-A4DD-52F0C55F0960 @default.
- Q87829268 P2860 Q87829268-C10B47F5-C2D1-4138-ABCE-0E0DDA02C293 @default.
- Q87829268 P2860 Q87829268-C40B5153-06F8-447A-807B-31B175328F94 @default.
- Q87829268 P2860 Q87829268-C6B453BF-C5BF-4272-9871-6E200E912822 @default.
- Q87829268 P2860 Q87829268-DA0826C4-4B44-4B6A-A50B-88510E66F38D @default.
- Q87829268 P2860 Q87829268-E5614EC0-DE4D-4376-B2F8-9AE61A705B14 @default.
- Q87829268 P2860 Q87829268-E5F509DA-E0E3-4C71-9A0C-34590D700DB3 @default.
- Q87829268 P2860 Q87829268-E8765010-063F-48FF-84AF-911777B3D00D @default.
- Q87829268 P2860 Q87829268-EEB507E9-C949-480D-BB06-9DB5C83208E1 @default.
- Q87829268 P2860 Q87829268-FB69F24E-D1D5-459B-851C-8928E06FDED6 @default.
- Q87829268 P2860 Q87829268-FDBCF6A9-6B41-4953-BC2C-E0B961F736AC @default.
- Q87829268 P2860 Q87829268-FEFC825B-7218-4FFC-8A28-779617E5A1B9 @default.
- Q87829268 P304 Q87829268-9EACDA84-A443-41A7-867B-216F5BD244C9 @default.
- Q87829268 P31 Q87829268-2A03AEE5-124E-4013-8A30-C0B296E9FCFA @default.
- Q87829268 P356 Q87829268-99B6F35C-7758-431E-A548-EF9C46F5A803 @default.
- Q87829268 P433 Q87829268-ED1FCE35-27F0-4A08-B93B-E9A07A2C36B9 @default.
- Q87829268 P478 Q87829268-356EC036-CF37-480A-9B4B-4372AB983CA8 @default.
- Q87829268 P50 Q87829268-9DD783FE-120A-4D73-851D-343D3F81D06C @default.
- Q87829268 P577 Q87829268-88A3EE89-AC70-420A-B42F-62A7AC93769C @default.
- Q87829268 P6216 Q87829268-e8f4860c-0057-430c-b179-5177a05f4565 @default.
- Q87829268 P698 Q87829268-055067CA-4A03-4689-9983-9043F25E1129 @default.
- Q87829268 P921 Q87829268-4F8098D1-B032-4197-91B8-CE4099B7888F @default.
- Q87829268 P932 Q87829268-A21EF941-EE4A-413B-BEE0-64F438A2E132 @default.
- Q87829268 P356 GFX378 @default.
- Q87829268 P698 29462348 @default.
- Q87829268 P1433 Q15710302 @default.
- Q87829268 P1476 "Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis" @default.
- Q87829268 P2093 "Alan D Salama" @default.
- Q87829268 P2093 "Anisha Tanna" @default.